I agree dabru
Tavr has been touted and seems mist likely as the prime tool
Infusion is small time let alone profitable and vaccines has been taken care of.
This is no typical cr and definitely won't be a spp.
A placement as I posted the other day seems to be a board seat, stake in the company whereby the stake comes at a price and will enable development if tavr etc
Nothing sure of course
- Forums
- ASX - By Stock
- AVR
- Ann: Extension of Voluntary Suspension
Ann: Extension of Voluntary Suspension, page-51
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.00 |
Change
0.000(0.00%) |
Mkt cap ! $295.9M |
Open | High | Low | Value | Volume |
$14.00 | $14.23 | $13.30 | $483.9K | 34.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.50 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 13.700 |
1 | 1000 | 13.510 |
1 | 200 | 13.500 |
1 | 7 | 13.300 |
1 | 70 | 13.100 |
Price($) | Vol. | No. |
---|---|---|
14.500 | 500 | 1 |
15.000 | 1000 | 1 |
15.150 | 149 | 1 |
15.500 | 44 | 1 |
15.700 | 277 | 1 |
Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |